ARPA-H Funding Will Support Teams to Advance Robotics Stroke Interventions

August 12, 2026—The Advanced Research Projects Agency for Health (ARPA-H), an agency within the United States Department of Health and Human Services, announced contract awards to seven teams through its Autonomous Interventions and Robotics (AIR) program to develop autonomous robotic systems and microbots for the treatment of stroke.

FastWave’s SPARC Pivotal Trial of Artero Peripheral IVL System Receives IDE Approval

August 11, 2026—FastWave Medical announced that it has received FDA approval of an investigational device exemption for the United States pivotal trial of the company’s Artero electric intravascular lithotripsy system for the treatment of peripheral artery disease.

Penumbra Appoints Dr. Donald Frei as Associate Chief Medical Officer of Neuro

August 11, 2026—Penumbra announced today that Donald Frei, MD, will serve as Associate Chief Medical Officer of Neuro.

Vexev Raises Funds to Support VxWave Autonomous Vascular Imaging Platform 

August 11, 2026—Vexev, an Australia-based medical robotics company, announced it has raised $6 million in new funding to accelerate the path to FDA 510(k) clearance and United States commercialization of its VxWave robotic tomographic ultrasound platform, which is designed to improve access to standardized vascular imaging.

Fluidx Medical Closes Financing to Advance Next-Generation Embolic Platforms

August 7, 2026—Fluidx Medical Technology, Inc., a developer of embolic technologies, announced the closing of financing that will fund the development and growth of the company’s portfolio of controllable embolic gels.

Salus Scientific Closes Series A Financing to Support Occupational Wellness Platform

August 6, 2026—Salus Scientific Corporation announced the closing of its oversubscribed Series A financing, raising a total of $10.1 million.

ALARA+ Coalition Launches Toolkits to Accelerate Adoption of Enhanced Radiation Protection

August 6, 2026—The Society for Cardiovascular Angiography & Interventions (SCAI) and the Society of Interventional Radiology announced that the release of the ALARA+ (“As Low And As Light As Reasonably Achievable”) Coalition’s resources to help hospital leadership and decisionmakers implement enhanced radiation and occupational safety guidelines for clinicians and staff working in catheterization labs.

Funding Will Advance Xeltis’ aXess Device United States Regulatory and Commercial Pathway

August 4, 2026—Xeltis, a Netherlands-based developer of implants that enable the natural creation of living and long-lasting vessels, announced that it had raised an additional €20.5 million of new funding from new and existing shareholders.